An ATP-activated, ligand-gated ion channel on a cholinergic presynaptic nerve terminal

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 5, 1996, Pages 1859-1863

  Sun, Xiao Ping ^a   Stanley, Elis Frank ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

autoreceptor; chicken ciliary ganglion; purinergic receptor; transmitter release

Indexed keywords

ADENOSINE TRIPHOSPHATE; AUTORECEPTOR; ION CHANNEL; PURINE RECEPTOR;

ANIMAL TISSUE; ARTICLE; CILIARY GANGLION; ENZYME ACTIVATION; ION CONDUCTANCE; LIGAND BINDING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; SYNAPTOSOME;

ADENOSINE TRIPHOSPHATE; ANIMALS; CHICK EMBRYO; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC CONDUCTIVITY; GANGLIA, PARASYMPATHETIC; ION CHANNEL GATING; ION CHANNELS; LIGANDS; MEMBRANE POTENTIALS; NEUROTRANSMITTER AGENTS; RECEPTORS, PURINERGIC; SURAMIN; SYNAPTIC MEMBRANES; SYNAPTIC TRANSMISSION;

EID: 0344705013     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.5.1859     Document Type: Article

References (30)

1. Silinsky E. M., Hunt, J. M., Solsona, C. S. & Hirsh, J. K. (1990) Ann. N.Y. Acad. Sci. 603, 324-334.
2. Silinsky, E. M. & Ginsborg, V. (1983) Nature (London) 305, 177-328.
3. Bennett M. R. & Ho, S. (1991) J. Physiol. (London) 440, 513-527.
4. Fu, W. M. & Poo, M. M. (1991) Neuron 6, 837-843.
5. Sperlagh, B. & Vizi, E. S. (1991) J. Neurochem. 56, 1466-1470.
6. Surprenant, A., Buell, G. & North, R. A. (1995) Trends Neurosci. 18, 224-229.
7. Bean, B. P. (1992) Trends Physiol. Sci. 13, 87-90.
8. Dubyak, O. R. & El-Moatassim, C. (1993) Am. J. Physiol. 265, C577-C606.
9. Stanley E. F. (1989) Brain Res. 505, 341-345.
10. Stanley, E. F. (1991) Neuron 7, 585-591.
11. Sun, X. P. & Stanley, E. F. (1993) Soc. Neurosci. Abstr. 19, 901.
12. Sun, X. P. & Stanley, E. F. (1994) Soc. Neurosci. Abstr. 20, 1120.
13. Stanley, E. & Goping, G. (1991) J. Neurosci. 11, 985-993.
14. Hamill, O. P., Marty, A., Neher, E., Sakmann, B. & Sigworth, F. J. (1981) Pflügers Arch. 391, 85-100.
15. Bean, B. P. (1990) J. Neurosci. 10, 1-10.
16. Hume, R. I. & Honig, M. G. (1986) J. Neurosci. 6, 681-690.
17. Thomas, S.A. & Hume. R. I. (1990) J. Physiol. (London) 430, 373-388.
18. Dünn, P. M. & Blakeley, A. G. H. (1988) Br. J. Pharmacol. 93, 243-245.
19. Inoue, R. & Brading, A. F. (1990) Br. J. Pharmacol. 100, 619-625.
20. Abbracchio, M. P. & Burnstock, G. (1994) Pharmacol. Therapeut. 64, 445-475.
21. Krishtal, O. A., Marchenko, S. M. & Pidoplichko, V. I. (1983) Neurosci. Lett. 35, 41-45.
22. Nakazawa, K., Inoue, K., Fujimori, K. & Takanaka, A. (1991) Pflügers Arch. 418, 214-219.
23. Silinsky, E. M. & Gerzanich, V. (1993) J. Physiol. (London) 464, 197-212.
24. Nakazawa, K., Inoue, K., Fujimori, K. & Takanaka, A. (1990) Neurosci. Lett. 119, 5-8.
25. Burnstock, G. & Kennedy, C. (1985) Gen. Pharmacol. 16, 433-440.
26. Zimmerman, H. (1994) Trends Neurosci. 17, 420-426.
27. Edwards, F. A. (1994) Curr. Opin. Neurobiol. 4, 347-352.
28. Dolphin, A. C. (1985) Trends Neurosci. 8, 376-378.
29. Scott, T. R. D. & Bennett, M. R. (1993) Br. J. Pharmacol. 110, 461-469.
30. Khakh, B. S., Surprenant, A. & Humphrey, P. P. A. (1995) Br. J. Pharmacol. 115, 177-185.